Teva Branded Pharmaceutical Products R&d Llc

This study tests an oral medication called TEV-56286 in 350 adults with multiple system atrophy (MSA), a rare and serious brain disorder. The goal is to see if the drug can slow disease progression and improve daily function over 48 weeks. Participants will be randomly assigned t…

This study tests the long-term safety of an oral drug called TEV-56286 for adults with multiple system atrophy (MSA), a rare and serious brain disorder. About 200 people who completed a prior study will take the drug for up to 100 weeks. The main goal is to see if the drug is saf…

This early-phase trial tests an experimental drug called TEV-56278, alone or with the immunotherapy pembrolizumab, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can…

This study tests a new inhaler that combines two medicines (fluticasone and albuterol) to see if it can prevent severe asthma attacks better than albuterol alone. About 2,700 adults with asthma who have had at least one severe attack in the past year will take part. The study las…